CLOV
Clover Health Investments, Corp.
$3.55
-0.05
(-1.39%)
Mkt Cap
1.84B
Volume
4,696,345
52W Range
1.58-3.92
Sector
Healthcare
Beta
2.45
EPS (TTM)
-0.11
P/E Ratio
-14.21
Revenue (TTM)
2.21B
Rev Growth (5Y)
+23.4%
EPS Growth (5Y)
N/A
Company Description
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.92B | 1.37B | 1.26B | 1.10B | 1.47B | 672.89M | 462.27M | 281.02M |
| Net Income | (85.55M) | (43.01M) | (213.36M) | (339.57M) | (587.76M) | (136.39M) | (363.74M) | (201.93M) |
| EPS | -0.17 | -0.09 | -0.45 | -0.71 | -1.25 | -0.23 | -0.90 | -4.81 |
| Free Cash Flow | (68.98M) | 33.29M | (116.45M) | (208.39M) | (283.05M) | (119.19M) | (159.90M) | (154.76M) |
| FCF / Share | -0.13 | 0.07 | -0.24 | -0.44 | -0.60 | -0.29 | -0.40 | -3.68 |
| Operating CF | (66.93M) | 34.84M | (115.87M) | (203.93M) | (282.33M) | (118.50M) | (159.88M) | (153.28M) |
| Total Assets | 541.01M | 580.74M | 570.67M | 808.62M | 950.80M | 267.25M | 100,346 | 210.60M |
| Total Debt | 0 | 0 | 4.66M | 5.86M | 27.83M | 138.36M | 0 | 49.25M |
| Cash & Equiv | 78.30M | 194.54M | 116.41M | 103.79M | 299.97M | 92.35M | 0 | 75.40M |
| Book Value | 308.70M | 341.14M | 286.39M | 356.89M | 535.41M | (617.10M) | (17,631) | (54.83M) |
| Return on Equity | -0.28 | -0.13 | -0.74 | -0.95 | -1.10 | N/A | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 749.19M | 487.71M | 496.65M | 477.62M | 462.33M | 336.96M | 330.99M | 356.26M | 346.92M | 510.25M | 306.03M | 320.14M |
| Net Income | 27.33M | (49.32M) | (24.38M) | (10.58M) | (1.27M) | (22.09M) | (9.15M) | 7.41M | (19.17M) | (70.47M) | (41.47M) | (28.81M) |
| EPS | 0.05 | -0.10 | -0.05 | -0.02 | -0.00 | -0.04 | -0.02 | 0.01 | -0.04 | -0.15 | -0.09 | -0.06 |
| Free Cash Flow | 107.04M | (68.75M) | 11.41M | 4.84M | (16.48M) | (86.15M) | 49.59M | 44.36M | 25.49M | (257.82M) | (19.02M) | 52.82M |
| FCF / Share | 0.20 | -0.13 | 0.02 | 0.01 | -0.03 | -0.18 | 0.10 | 0.09 | 0.05 | -0.54 | -0.04 | 0.11 |
| Operating CF | 107.89M | (68.15M) | 12.10M | 5.41M | (16.29M) | (85.83M) | 49.99M | 44.76M | 25.93M | (258.09M) | (18.78M) | 53.17M |
| Total Assets | 697.73M | 541.01M | 559.66M | 574.99M | 583.72M | 580.74M | 653.01M | 674.21M | 671.77M | 570.67M | 1.06B | 1.26B |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 3.67M | 4.01M | 4.34M | 4.66M | 4.96M | 5.35M |
| Cash & Equiv | 173.26M | 78.30M | 190.06M | 188.65M | 155.44M | 194.54M | 287.96M | 254.77M | 208.25M | 116.41M | 299.01M | 310.08M |
| Book Value | 339.43M | 308.70M | 340.93M | 344.18M | 336.07M | 341.14M | 342.17M | 324.89M | 292.47M | 286.39M | 321.85M | 330.57M |
| Return on Equity | 0.08 | -0.16 | -0.07 | -0.03 | -0.00 | -0.06 | -0.03 | 0.02 | -0.07 | -0.25 | -0.13 | -0.09 |
CLOV News
Clover Health Investments, Corp. (CLOV) Q1 2026 Earnings Call Transcript
Clover Health Q1 Earnings Meet Estimates, Sales Beat, Membership Rises
Clover Health Investments, Corp. (CLOV) Meets Q1 Earnings Estimates
Clover Health Reports First Quarter 2026 Results
Butterfly Network, Inc. (BFLY) Reports Q1 Loss, Beats Revenue Estimates
Here's Why You Should Retain Clover Stock in Your Portfolio for Now
Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026
Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership
Clover Health Investments Target of Unusually Large Options Trading (NASDAQ:CLOV)
Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026